You’ve had your annual bloods done. Your doctor calls with the results: “Your LDL cholesterol is elevated. We should start a statin.”
You leave the consultation feeling anxious, confused, and possibly already searching whether statins are safe. But here’s the question nobody asked: is your elevated LDL actually putting your heart and brain at risk, or is there more to the story?
A standard lipogram gives you four numbers: total cholesterol, LDL, HDL, and triglycerides. For decades, the conversation has centred almost entirely on LDL. High LDL equals high risk. Prescribe a statin. Move on.
But cardiovascular risk is not a single-number problem. It’s a story, and LDL is only one character in it.
An LDL of 4.5 mmol/L in a 38-year-old woman who exercises regularly, has no family history of heart disease, a high HDL, low triglycerides, a normal hsCRP, and no insulin resistance carries a very different risk profile to the same LDL in a 55-year-old man who smokes, has a family history of early cardiac events, elevated triglycerides, low HDL, and systemic inflammation.
The number is the same. The clinical significance is worlds apart.
In certain contexts, a raised LDL can be what we call a functional elevation, meaning the LDL is elevated for a physiological reason that does not necessarily equate to increased cardiovascular risk.
Common scenarios include women in perimenopause (oestrogen decline directly affects lipid metabolism), people following very low-carbohydrate or ketogenic diets, and lean, metabolically healthy individuals whose lipid profiles shift seasonally or in response to acute changes.
In these cases, prescribing a statin based purely on the LDL number without interrogating the context can be premature.
When I assess cardiovascular risk, I don’t just look at the lipogram. I build a picture. That includes:
Triglyceride-to-HDL ratio — one of the most underused markers in routine practice. A high ratio is a strong surrogate marker for insulin resistance and for small, dense LDL particles (the type that actually penetrate arterial walls and drive atherosclerosis).
hsCRP (high-sensitivity C-reactive protein) tells me about systemic inflammation, which is an independent risk factor for cardiovascular disease. You can have a perfect lipogram and still have elevated vascular inflammation.
Lipoprotein(a), or Lp(a), is a genetically determined lipoprotein that significantly increases cardiovascular and stroke risk when elevated. It’s not affected by diet or lifestyle, and it’s not included in a standard lipogram. Yet around 20% of the global population has elevated Lp(a). Because it’s genetic, it only needs to be tested once.
Fasting insulin and metabolic markers, because insulin resistance is one of the most potent drivers of atherogenic dyslipidaemia — the pattern of high triglycerides, low HDL, and small dense LDL that actually increases cardiovascular risk.
Family history remains one of the most powerful risk stratification tools we have. A first-degree relative with premature cardiovascular disease significantly elevates your own risk, regardless of what your lipogram says today.
I believe strongly that management should be proportional to risk, and that the conversation should be honest, balanced, and free of dogma in either direction.
For some patients, the answer is absolutely a statin. If you have familial hypercholesterolaemia, established cardiovascular disease, diabetes with high risk, or multiple converging risk factors, the evidence for statin therapy is robust and the benefit is clear.
For other patients, the answer is lifestyle modification with close monitoring. Changes to diet, exercise, sleep, stress management, and alcohol intake can meaningfully shift metabolic and lipid profiles.
And for some patients, the answer is “let’s investigate further before we decide.” Let’s check your Lp(a). Let’s look at your inflammatory markers. Let’s understand the full risk profile before we commit to lifelong medication.
A high LDL on a lipogram is not an automatic prescription for a statin. And a “normal” lipogram is not a guarantee that your cardiovascular risk is low. The truth lives in the context: your metabolic health, your inflammatory status, your genetic risk, your family history, and the pattern of your lipid profile as a whole.
Your cholesterol number is part of the story. But it’s not the whole story. And you deserve a clinician who reads the whole thing.
Dr Robyn Bradfield is the founder of Bloodfields, a virtual investigative blood analysis practice. If you’d like your lipid and cardiovascular risk profile assessed in full context, you can book through our website.